Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
Sales | 3,036,000 | 2,909,000 | 2,652,000 | 2,492,000 | 2,686,000 |
Cost of Goods | 545,000 | 673,000 | 546,000 | 510,000 | 545,000 |
Gross Profit | 2,794,000 | 2,823,000 | 2,548,000 | 2,403,000 | 2,456,000 |
Operating Expenses | 1,837,000 | 1,921,000 | 1,663,000 | 1,706,000 | 1,594,000 |
Operating Income | 654,000 | 315,000 | 443,000 | 276,000 | 547,000 |
Other Income | 308,000 | 463,000 | 369,000 | 360,000 | 315,000 |
Pre-tax Income | 962,000 | 778,000 | 812,000 | 636,000 | 862,000 |
Income Tax | 269,000 | 218,000 | 213,000 | 175,000 | 259,000 |
Net Income Continuous | 535,000 | 503,000 | 582,000 | 422,000 | 575,000 |
Net Income Discontinuous | 157,000 | 55,000 | 14,000 | 35,000 | 27,000 |
Net Income | $692,000 | $558,000 | $596,000 | $457,000 | $602,000 |
EPS Basic Total Ops | 0.18 | 0.15 | 0.15 | 0.12 | 0.16 |
EPS Basic Continuous Ops | 0.14 | 0.13 | 0.15 | 0.11 | 0.15 |
EPS Basic Discontinuous Ops | 0.04 | 0.01 | 0.00 | 0.01 | 0.01 |
EPS Diluted Total Ops | 0.18 | 0.14 | 0.15 | 0.12 | 0.15 |
EPS Diluted Continuous Ops | 0.14 | 0.13 | 0.15 | 0.11 | 0.15 |
EPS Diluted Discontinuous Ops | 0.04 | 0.01 | 0.00 | 0.01 | 0.01 |
EBITDA(a) | $788,000 | $445,000 | $571,000 | $406,000 | $661,000 |